What is Eclipse Orthopaedics?
Eclipse Orthopaedics is dedicated to refining internal fixation techniques within orthopaedic trauma surgery. The company's flagship innovation is the Radioscopic Targeting Attachment (RTA), a device engineered to streamline the distal locking process for surgeons. This technology aims to enhance patient outcomes by simplifying surgical steps, reducing operative time, minimizing radiation exposure for both patients and medical staff, and improving the overall safety and precision of leg and hip fracture surgeries. Their primary market includes general surgeons in community hospitals.
How much funding has Eclipse Orthopaedics raised?
Eclipse Orthopaedics has raised a total of $19K across 1 funding round:
Debt
$19K
Debt (2021): $19K with participation from PPP
Key Investors in Eclipse Orthopaedics
PPP
Public-Private Partnership
What's next for Eclipse Orthopaedics?
With the recent injection of moderate growth capital, Eclipse Orthopaedics is poised for significant expansion. This funding is expected to accelerate the development and commercialization of the RTA device, enabling the company to scale its manufacturing capabilities and broaden its market reach. The Series A/B growth stage suggests a strategic focus on solidifying its position in the orthopaedic trauma market, potentially through increased sales efforts, strategic partnerships, and further product development to address unmet clinical needs.
See full Eclipse Orthopaedics company page
